Cellectar Biosciences Inc (CLRB)
3.38
-0.04
(-1.17%)
USD |
NASDAQ |
May 06, 14:37
Cellectar Biosciences Cash from Operations (Quarterly): -9.596M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -9.596M |
| September 30, 2023 | -8.068M |
| June 30, 2023 | -7.530M |
| March 31, 2023 | -7.184M |
| December 31, 2022 | -7.412M |
| September 30, 2022 | -7.013M |
| June 30, 2022 | -5.758M |
| March 31, 2022 | -5.040M |
| December 31, 2021 | -4.511M |
| September 30, 2021 | -6.429M |
| June 30, 2021 | -6.876M |
| March 31, 2021 | -4.753M |
| December 31, 2020 | -3.869M |
| September 30, 2020 | -3.502M |
| June 30, 2020 | -3.050M |
| March 31, 2020 | -3.512M |
| December 31, 2019 | -2.681M |
| September 30, 2019 | -3.544M |
| June 30, 2019 | -2.653M |
| March 31, 2019 | -2.815M |
| December 31, 2018 | -2.744M |
| September 30, 2018 | -2.969M |
| June 30, 2018 | -2.546M |
| March 31, 2018 | -3.184M |
| December 31, 2017 | -2.826M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.543M |
| June 30, 2017 | -2.664M |
| March 31, 2017 | -2.987M |
| December 31, 2016 | -2.349M |
| September 30, 2016 | -2.214M |
| June 30, 2016 | -1.902M |
| March 31, 2016 | -1.818M |
| December 31, 2015 | -1.494M |
| September 30, 2015 | -2.165M |
| June 30, 2015 | -2.187M |
| March 31, 2015 | -2.366M |
| December 31, 2014 | -2.141M |
| September 30, 2014 | -2.097M |
| June 30, 2014 | -2.008M |
| March 31, 2014 | -2.595M |
| December 31, 2013 | -2.679M |
| September 30, 2013 | -2.553M |
| June 30, 2013 | -2.034M |
| March 31, 2013 | -1.889M |
| December 31, 2012 | -1.694M |
| September 30, 2012 | -1.691M |
| June 30, 2012 | -1.498M |
| March 31, 2012 | -1.703M |
| December 31, 2011 | -1.536M |
| September 30, 2011 | -1.531M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-9.596M
Minimum
Dec 2023
-2.653M
Maximum
Jun 2019
-5.42M
Average
-5.040M
Median
Mar 2022
Cash from Operations (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -9.008M |
| Eli Lilly and Co | 1.166B |
| Actinium Pharmaceuticals Inc | -7.374M |
| Bristol-Myers Squibb Co | 2.834B |
| Altimmune Inc | -16.53M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.2668M |
| Cash from Financing (Quarterly) | 0.441M |
| Free Cash Flow | -33.24M |
| Free Cash Flow Per Share (Quarterly) | -0.6551 |
| Free Cash Flow Yield | -80.47% |